MK-0952

Names

[ Name ]:
MK-0952

Biological Activity

[Description]:

MK-0952 is a selective and orally active PDE4 inhibitor, with an IC50 of 0.53 nM. MK-0952 has the potential for Alzheimer’s disease study[1][2].

[Related Catalog]:

Signaling Pathways >> Metabolic Enzyme/Protease >> Phosphodiesterase (PDE)

Research Areas >> Neurological Disease

[Target]

PDE4:0.53 nM (IC50)

[In Vivo]

MK-0952 (10 mg/kg) induces malaise in the rat[1].

[References]

[1]. Michel Gallant, et al. Discovery of MK-0952, a Selective PDE4 Inhibitor for the Treatment of Long-Term Memory Loss and Mild Cognitive Impairment. Epub 2010 Sep 21.

[2]. Tingting Pan, et al. Dual Functional Cholinesterase and PDE4D Inhibitors for the Treatment of Alzheimer's Disease: Design, Synthesis and Evaluation of tacrine-pyrazolo[3,4-b]pyridine Hybrids. Behav Brain Res. 2016 Apr 15;303:26-33.

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₈H₂₂FN₃O₄

[ Molecular Weight ]:
483.49000

[ Exact Mass ]:
483.15900

[ PSA ]:
104.78000

[ LogP ]:
4.84690

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.